Table 5.
Toxicities by CTCAE v4.05
| Toxicity | Early (beginning of treatment up to 3 months after completion) (%) | Late (3 months and later) (%) |
|---|---|---|
| GI | ||
| None | N = 5 (16) | N = 20 (64) |
| Mild (Grade I–II) | N = 21 (68) | N = 2 (7) |
| Severe (Grade III–IV) | N = 1 (3) | N = 1 (3) |
| Not reported | N = 4 (13) | N = 8 (26) |
| GU | ||
| None | N = 11 (35) | N = 21 (68) |
| Mild (Grade I–II) | N = 16 (52) | N = 5 (16) |
| Severe (Grade ≥III) | N = 0 (0) | N = 0 (0) |
| Not reported | N = 4 (13) | N = 5 (16) |
| Vaginitis | ||
| None | N = 9 (29) | N = 20 (64) |
| Mild (Grade I–II) | N = 20 (64) | N = 2 (7) |
| Severe (Grade ≥III) | N = 0 (0) | N = 0 (0) |
| Not reported | N = 2 (7) | N = 9 (29) |
| Hematotoxicity | ||
| Leukopenia | ||
| None | N = 0 | – |
| Grade I–II | N = 22 (71) | – |
| Grade III | N = 8 (26) | – |
| Grade IV | N = 1 (3) | – |
| Anemia | ||
| None | N = 8 (26) | – |
| Grade I–II | N = 20 (64) | – |
| Grade III | N = 3 (10) | – |
| Thrombopenia | ||
| None | N = 20 (64) | – |
| Grade I–II | N = 8 (26) | – |
| Grade III | N = 2 (7) | – |
| Grade IV | N = 1 (3) | – |
GI gastrointestinal toxicity, GU genitourinary toxicity, dysuria